Skip to content

Comparison of the Genotoxicity of Desflurane and Propofol

Genotoxic Effects of Desflurane and Propofol Anesthesia in Patients Undergoing Lumbar Disc Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05185167
Enrollment
30
Registered
2022-01-11
Start date
2022-01-17
Completion date
2022-03-20
Last updated
2022-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, DNA Damage

Keywords

Desflurane, Intravenous anesthetics, propofol, comet essay

Brief summary

The purpose of this study is to evaluate if the anesthetics propofol and desflurane can damage DNA according to comet essay in patients submitted to lumbar disc surgery.

Detailed description

It is expected that DNA damage information provide the possible genotoxic effects of inhalational and intravenous anesthetics and contribute to the establishment of strategies aimed at reducing the risks to exposed patients.

Interventions

DRUGAnesthetics, General Desflurane Maintenance

Comparison of dna damage of desflurane maintenance with propofol maintenance according to comet analysis

DRUGAnesthetics, General Propofol Maintenance

Comparison of dna damage of propofol maintenance with desflurane maintenance according to comet analysis

Sponsors

Muğla Sıtkı Koçman University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
DIAGNOSTIC
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

1. Ability to understand and willingness to sign an informed consent form 2. Elective lumbar spinal surgery that will take at least 120 minutes, 3. American Society of Anesthesiologists (ASA) physical status I and II

Exclusion criteria

1. Patients with ASA physical status III or IV disease 2. Chronic systemic disease (diabetes mellitus,chronic pulmonary disorders, chronic kidney and liver disorders) 3. Smoking or alcohol consumption 4. Recently received radiation, chemotherapy 5. Malignancy 6. Patients who will receive blood transfusion during the operation 7. Users of antioxidant supplements 8. Patients who have received general anesthesia in the last three months 9. Patients with known occupational exposures (operating room personnel, chemical plant worker

Design outcomes

Primary

MeasureTime frameDescription
Intensity of the DNA tail detected by using Comet Assay IV Version 4.3.2 for Basler FireWireBefore anesthesia inductionThe blood samples that evaluate with comet analysis aim to detect the intensity of the DNA tail, and the tail greater, the greater the damage.
Head length of DNA detected by using Comet Assay IV Version 4.3.2 for Basler FireWireBefore anesthesia inductionThe blood samples that evaluate with comet analysis aim to detect the head length of DNA, the head greater, the smaller the damage.
Tail length of DNA detected by using Comet Assay IV Version 4.3.2 for Basler FireWirebefore anesthesia inductionThe blood samples that evaluate with comet analysis aim to detect the tail length of DNA, the head greater, the greater the damage.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026